Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-174417

Options or other derivatives

  • Chief Executive Officer acquired 24,081 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

TABUTEAU HERRIOT · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-21 Grant or award : show line 1 in the form Performance Stock Units +24,081 24,081 D
Loading xslF345X06/ownership.xml…